OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study
Yvette Drew, Jae‐Weon Kim, Richard T. Penson, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 1, pp. 50-62
Open Access | Times Cited: 30
Yvette Drew, Jae‐Weon Kim, Richard T. Penson, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 1, pp. 50-62
Open Access | Times Cited: 30
Showing 26-50 of 30 citing articles:
Research advances in immunotherapy combined with DNA damage response inhibitors for liver cancer therapy
Yang Chen, Tao Tao, Yijie Wu, et al.
Journal of Cancer Metastasis and Treatment (2024) Vol. 10, pp. 14-14
Open Access
Yang Chen, Tao Tao, Yijie Wu, et al.
Journal of Cancer Metastasis and Treatment (2024) Vol. 10, pp. 14-14
Open Access
Combining immunotherapy with PARP inhibitors. Is it possible to find the way through?
Georgios Papageorgiou, Nikolaos Skouteris, Kleopatra Eleftheriou, et al.
Immunotherapy (2024), pp. 1-5
Closed Access
Georgios Papageorgiou, Nikolaos Skouteris, Kleopatra Eleftheriou, et al.
Immunotherapy (2024), pp. 1-5
Closed Access
Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging in Magnetic Resonance in the Assessment of Peritoneal Recurrence of Ovarian Cancer in Patients with or Without BRCA Mutation
Melania Jankowska-Lombarska, Laretta Grabowska-Derlatka, Leszek Kraj, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3738-3738
Open Access
Melania Jankowska-Lombarska, Laretta Grabowska-Derlatka, Leszek Kraj, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3738-3738
Open Access
Integrated immunogenomic analyses of high-grade serous ovarian cancer reveal vulnerability to combination immunotherapy
Raphael Gronauer, Leonie Madersbacher, Pablo Monfort‐Lanzas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Raphael Gronauer, Leonie Madersbacher, Pablo Monfort‐Lanzas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Research progress of immune checkpoint inhibitors in ovarian cancer
Lingli Zhao, Yanhong Zhai, Gaoli Niu
Exploration of Immunology (2024), pp. 853-870
Open Access
Lingli Zhao, Yanhong Zhai, Gaoli Niu
Exploration of Immunology (2024), pp. 853-870
Open Access
